Results 1 to 10 of about 3,405 (181)

Latent tuberculosis

Lung India, 2016
Ajaz Nabi Koul
doaj   +3 more sources

Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics

AJPM Focus, 2023
Introduction: Prevention of tuberculosis disease through diagnosis and treatment of latent tuberculosis infection is critical for achieving tuberculosis elimination in the U.S.
Laura A. Vonnahme, MPH, Julia Raykin, PhD, Matthew Jones, MS, Jee Oakley, MPH, Jon Puro, MPA, Adam Langer, DVM, Kaylynn Aiona, MPH, Robert Belknap, MD, Tracy Ayers, PhD, Jonathan Todd, PhD, Kathryn Winglee, PhD   +10 more
doaj   +1 more source

Latent Tuberculosis Infection in Potential Renal Transplant Recipients and Live Donors in a Tertiary Level Transplant Center in Nepal

Journal of Nobel Medical College, 2022
Background: Active tuberculosis in transplant recipients can result from latent infection with Mycobacterium Tuberculosis in the transplant recipients, donor tissue, or de novo post-transplant infection.
Suresh Maharjan, Bikash Khatri, Deepa Chemjong, Bijay Khatri, Dibya Singh Shah   +4 more
doaj   +1 more source

Interferon-gamma assay and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease: a summarization study

Egyptian Journal of Chest Disease and Tuberculosis, 2021
Background Latent tuberculosis is an important clinical problem. This problem might be significant in some specific groups of patients. The screening for latent tuberculosis is recommended for management of those patients at risk.
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit   +1 more
doaj   +1 more source

Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans. [PDF]

PLoS ONE, 2014
Very little is known about the growth and mutation rates of Mycobacterium tuberculosis during latent infection in humans. However, studies in rhesus macaques have suggested that latent infections have mutation rates that are higher than that observed ...
Roberto Colangeli, Vic L Arcus, Ray T Cursons, Ali Ruthe, Noel Karalus, Kathy Coley, Shannon D Manning, Soyeon Kim, Emily Marchiano, David Alland   +9 more
doaj   +1 more source

Testing for Latent Tuberculosis [PDF]

Clinical Medicine & Research, 2004
Tuberculosis (TB) is a common cause of morbidity and mortality worldwide. The number of new cases continues to increase despite intense efforts to eradicate the disease. According to the World Health Organization, the global incidence rate of TB increased to 8.8 million cases in 2002 with a growth rate of 2.4% per year.1 In the United States, about ...
Asad, Ayub, Steven H, Yale, Kurt D, Reed, Rana M, Nasser, Steven R, Gilbert   +4 more
openaire   +2 more sources

Acceptance and influencing factors of preventive treatment for latent tuberculosis infection: a review

Zhongguo gonggong weisheng, 2023
Preventive treatment for latent tuberculosis infection is one of the key measures to achieve the goal of ending tuberculosis. Currently, the acceptance of preventive treatment among different populations is unclear.
Yemin YUAN, Shixue LI, Chengchao ZHOU
doaj   +1 more source

Tuberculosis and latent tuberculosis in prison inmates [PDF]

Revista de Saúde Pública, 2012
OBJECTIVE: To estimate the prevalences of tuberculosis and latent tuberculosis in inmates. METHODS: Observational study was carried out with inmates of a prison and a jail in the State of São Paulo, Southeastern Brazil, between March and December of 2008. Questionnaires were used to collect sociodemographic and epidemiological data.
Nogueira, Péricles Alves, Abrahão, Regina Maura Cabral de Melo, Galesi, Vera Maria Neder   +2 more
openaire   +6 more sources

A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent Tuberculosis

Frontiers in Chemistry, 2020
Tuberculosis is one of the deadliest infectious diseases worldwide and the prevalence of latent tuberculosis acts as a huge roadblock in the global effort to eradicate tuberculosis.
Ushashi Banerjee, Santhosh Sankar, Amit Singh, Nagasuma Chandra, Nagasuma Chandra   +4 more
doaj   +1 more source

Immune Subtyping in Latent Tuberculosis [PDF]

Frontiers in Immunology, 2021
Latent tuberculosis infection (LTBI) poses a major roadblock in the global effort to eradicate tuberculosis (TB). A deep understanding of the host responses involved in establishment and maintenance of TB latency is required to propel the development of sensitive methods to detect and treat LTBI.
Ushashi Banerjee, Priyanka Baloni, Amit Singh, Nagasuma Chandra, Nagasuma Chandra   +4 more
openaire   +3 more sources